Oct 12 2026 09:41 PM EST

FIGS Shares Rise on Strong Q2 Earnings and Raised FY Guidance

FIGS, Inc. (NYSE: FIGS) jumped 5.5% to $16.65 on Oct 12, after reporting a second‑quarter earnings beat and raising its full‑year revenue guidance. The move coincided with a wave of analyst price‑target upgrades and a notable rise in short‑interest, prompting investors to reassess the company’s growth trajectory.

Q2 FY 2026 results released on Aug 6 showed adjusted earnings per share of $0.15 versus the consensus of $0.07, a 150% surprise. Revenue reached $196.6 million, beating estimates by 6.5% and growing 28.8% YoY. Gross margin expanded to 75.2% (+820 bps YoY), while operating margin rose to 17.9% (+11.4 pp YoY). Free cash flow surged to $44.3 million, a 427% YoY increase.

Guidance Lift Reinforces Growth Outlook

Management raised FY 2026 revenue guidance to roughly $757.3 million, up from the analyst consensus of $729.1 million, and signaled near‑20% net‑revenue growth versus FY 2025. GAAP gross margin was guided at about 69.5%, reflecting tariff‑refund assumptions. The outlook for Q3 and Q4 was set at ~20% and ~10% YoY growth, respectively.

Analyst Reaction and Valuation Shift

Following the earnings release, several brokerages raised price targets: Goldman Sachs to $16, Barclays to $20, and Morgan Stanley to $15. The consensus rating remains “Hold” with an average target of $13.42, but S&P Global analysts have a “Buy” consensus averaging $18.63. The stock’s YTD gain of 23.9% outperforms the Retail‑Wholesale sector’s –4.4% decline.

Operational Drivers Behind the Beat

The company credited stronger customer engagement – active customers now exceed 3 million with net revenue per active customer up 2% YoY to $209 – and product innovation, including new scrub styles and high‑profile collaborations (Star Wars, Spider‑Man). International revenue grew 55.1% YoY, with the market footprint expanding from 32 to 85 countries, driven by entries in China, Japan, South Korea and Latin America. The TEAMS B2B platform and Community Hubs contributed recurring institutional orders.

Macro Context and Risks

U.S. Q2 2026 GDP was revised to 2.2%, with consumer spending up 3.8%, providing a modest tailwind for discretionary apparel spend. However, higher 10‑year Treasury yields could increase hospitals’ cost of capital, potentially shaving $12‑15 million (≈1% of FY revenue) from addressable spend. A 100 bp Fed rate hike historically depresses FIGS by roughly –1.2% on day 0 and –0.6% after six months. Geopolitical tensions, notably a prolonged Strait of Hormuz closure, raise inflationary pressure and could trigger tariff escalations up to 15%, which would compress margins.

Short interest has climbed sharply, reaching 17 million shares (≈10% of outstanding) – a 108% increase year‑over‑year – suggesting heightened speculation and potential for short‑cover dynamics. Insider activity shows executive chair Heather Hasson exercising options and selling shares in March, but no net purchases were recorded.

Outlook and Uncertainties

The upside to FIGS hinges on the continued rollout of its international expansion, the ability of the TEAMS platform to sustain institutional order flow, and the resilience of gross margins amid potential tariff and input‑cost pressures. The proposed “Healthcare is Human Act,” which would grant a tax credit to healthcare workers, could further boost demand for the company’s professional‑apparel offering. Conversely, slower consumer spending, unexpected Fed tightening, or a rise in tariffs could erode the growth narrative.